Safety of Combined Intravenous Antibiotic and Bacteriophage Therapy in Adults With Cystic Fibrosis and Antibiotic-Resistant Lung Infections

Clinical trial NCT07280598 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07280598
Sponsor: University of California, San Diego
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

CF - Cystic Fibrosis Klebsiella Pneumoniae Infection E Coli Infections Staphylococcus Aureus Infection Achromobacter Stenotrophomonas Maltophilia Infection

Start date: 2025-12-31
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.